Genomic Alterations in Primary Gastric Adenocarcinomas Correlate with Clinicopathological Characteristics and Survival

Background & aims: Pathogenesis of gastric cancer is driven by an accumulation of genetic changes that to a large extent occur at the chromosomal level. In order to investigate the patterns of chromosomal aberrations in gastric carcinomas, we performed genome‐wide microarray based comparative ge...

Full description

Saved in:
Bibliographic Details
Main Authors: Marjan M. Weiss, Ernst J. Kuipers, Cindy Postma, Antoine M. Snijders, Daniel Pinkel, Stefan G. M. Meuwissen, Donna Albertson, Gerrit A. Meijer
Format: Article
Language:English
Published: Wiley 2004-01-01
Series:Cellular Oncology
Online Access:http://dx.doi.org/10.1155/2004/454238
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832562995752861696
author Marjan M. Weiss
Ernst J. Kuipers
Cindy Postma
Antoine M. Snijders
Daniel Pinkel
Stefan G. M. Meuwissen
Donna Albertson
Gerrit A. Meijer
author_facet Marjan M. Weiss
Ernst J. Kuipers
Cindy Postma
Antoine M. Snijders
Daniel Pinkel
Stefan G. M. Meuwissen
Donna Albertson
Gerrit A. Meijer
author_sort Marjan M. Weiss
collection DOAJ
description Background & aims: Pathogenesis of gastric cancer is driven by an accumulation of genetic changes that to a large extent occur at the chromosomal level. In order to investigate the patterns of chromosomal aberrations in gastric carcinomas, we performed genome‐wide microarray based comparative genomic hybridisation (microarray CGH). With this recently developed technique chromosomal aberrations can be studied with high resolution and sensitivity. Methods: Array CGH was applied to a series of 35 gastric adenocarcinomas using a genome‐wide scanning array with 2275 BAC and P1 clones spotted in triplicate. Each clone contains at least one STS for linkage to the sequence of the human genome. These arrays provide an average resolution of 1.4 Mb across the genome. DNA copy number changes were correlated with clinicopathological tumour characteristics as well as survival. Results: All thirty‐five cancers showed chromosomal aberrations and 16 of the 35 tumours showed one or more amplifications. The most frequent aberrations are gains of 8q24.2, 8q24.1, 20q13.12, 20q13.2, 7p11.2, 1q32.3, 8p23.1–p23.3, losses of 5q14.1, 18q22.1, 19p13.12–p13.3, 9p21.3–p24.3, 17p13.1–p13.3, 13q31.1, 16q22.1, 21q21.3, and amplifications of 7q21–q22, and 12q14.1–q21.1. These aberrations were correlated to clinicopathological characteristics and survival. Gain of 1q32.3 was significantly correlated with lymph node status (p=0.007). Tumours with loss of 18q22.1, as well as tumours with amplifications were associated with poor survival (p=0.02, both). Conclusions: Microarray CGH has revealed several chromosomal regions that have not been described before in gastric cancer at this frequency and resolution, such as amplification of at 7q21–q22 and 12q14.1–q21.1, as well gains at 1q32.3, 7p11.2, and losses at 13q13.1. Interestingly, gain of 1q32.3 and loss of 18q22.1 are associated with a bad prognosis indicating that these regions could harbour gene(s) that may determine aggressive tumour behaviour and poor clinical outcome.
format Article
id doaj-art-0c6ce998c9d4428aa9cc1673170f7322
institution Kabale University
issn 1570-5870
1875-8606
language English
publishDate 2004-01-01
publisher Wiley
record_format Article
series Cellular Oncology
spelling doaj-art-0c6ce998c9d4428aa9cc1673170f73222025-02-03T01:21:08ZengWileyCellular Oncology1570-58701875-86062004-01-01265-630731710.1155/2004/454238Genomic Alterations in Primary Gastric Adenocarcinomas Correlate with Clinicopathological Characteristics and SurvivalMarjan M. Weiss0Ernst J. Kuipers1Cindy Postma2Antoine M. Snijders3Daniel Pinkel4Stefan G. M. Meuwissen5Donna Albertson6Gerrit A. Meijer7Department of Gastroenterology, VU University Medical Centre, Amsterdam, The NetherlandsDepartment of Gastroenterology and Hepatology, Erasmus University Medical Centre, Rotterdam, The NetherlandsDepartment of Pathology VU University Medical Centre, Amsterdam, The NetherlandsUCSF Cancer Center, San Francisco, California, USAUCSF Cancer Center, San Francisco, California, USADepartment of Gastroenterology, VU University Medical Centre, Amsterdam, The NetherlandsUCSF Cancer Center, San Francisco, California, USADepartment of Pathology VU University Medical Centre, Amsterdam, The NetherlandsBackground & aims: Pathogenesis of gastric cancer is driven by an accumulation of genetic changes that to a large extent occur at the chromosomal level. In order to investigate the patterns of chromosomal aberrations in gastric carcinomas, we performed genome‐wide microarray based comparative genomic hybridisation (microarray CGH). With this recently developed technique chromosomal aberrations can be studied with high resolution and sensitivity. Methods: Array CGH was applied to a series of 35 gastric adenocarcinomas using a genome‐wide scanning array with 2275 BAC and P1 clones spotted in triplicate. Each clone contains at least one STS for linkage to the sequence of the human genome. These arrays provide an average resolution of 1.4 Mb across the genome. DNA copy number changes were correlated with clinicopathological tumour characteristics as well as survival. Results: All thirty‐five cancers showed chromosomal aberrations and 16 of the 35 tumours showed one or more amplifications. The most frequent aberrations are gains of 8q24.2, 8q24.1, 20q13.12, 20q13.2, 7p11.2, 1q32.3, 8p23.1–p23.3, losses of 5q14.1, 18q22.1, 19p13.12–p13.3, 9p21.3–p24.3, 17p13.1–p13.3, 13q31.1, 16q22.1, 21q21.3, and amplifications of 7q21–q22, and 12q14.1–q21.1. These aberrations were correlated to clinicopathological characteristics and survival. Gain of 1q32.3 was significantly correlated with lymph node status (p=0.007). Tumours with loss of 18q22.1, as well as tumours with amplifications were associated with poor survival (p=0.02, both). Conclusions: Microarray CGH has revealed several chromosomal regions that have not been described before in gastric cancer at this frequency and resolution, such as amplification of at 7q21–q22 and 12q14.1–q21.1, as well gains at 1q32.3, 7p11.2, and losses at 13q13.1. Interestingly, gain of 1q32.3 and loss of 18q22.1 are associated with a bad prognosis indicating that these regions could harbour gene(s) that may determine aggressive tumour behaviour and poor clinical outcome.http://dx.doi.org/10.1155/2004/454238
spellingShingle Marjan M. Weiss
Ernst J. Kuipers
Cindy Postma
Antoine M. Snijders
Daniel Pinkel
Stefan G. M. Meuwissen
Donna Albertson
Gerrit A. Meijer
Genomic Alterations in Primary Gastric Adenocarcinomas Correlate with Clinicopathological Characteristics and Survival
Cellular Oncology
title Genomic Alterations in Primary Gastric Adenocarcinomas Correlate with Clinicopathological Characteristics and Survival
title_full Genomic Alterations in Primary Gastric Adenocarcinomas Correlate with Clinicopathological Characteristics and Survival
title_fullStr Genomic Alterations in Primary Gastric Adenocarcinomas Correlate with Clinicopathological Characteristics and Survival
title_full_unstemmed Genomic Alterations in Primary Gastric Adenocarcinomas Correlate with Clinicopathological Characteristics and Survival
title_short Genomic Alterations in Primary Gastric Adenocarcinomas Correlate with Clinicopathological Characteristics and Survival
title_sort genomic alterations in primary gastric adenocarcinomas correlate with clinicopathological characteristics and survival
url http://dx.doi.org/10.1155/2004/454238
work_keys_str_mv AT marjanmweiss genomicalterationsinprimarygastricadenocarcinomascorrelatewithclinicopathologicalcharacteristicsandsurvival
AT ernstjkuipers genomicalterationsinprimarygastricadenocarcinomascorrelatewithclinicopathologicalcharacteristicsandsurvival
AT cindypostma genomicalterationsinprimarygastricadenocarcinomascorrelatewithclinicopathologicalcharacteristicsandsurvival
AT antoinemsnijders genomicalterationsinprimarygastricadenocarcinomascorrelatewithclinicopathologicalcharacteristicsandsurvival
AT danielpinkel genomicalterationsinprimarygastricadenocarcinomascorrelatewithclinicopathologicalcharacteristicsandsurvival
AT stefangmmeuwissen genomicalterationsinprimarygastricadenocarcinomascorrelatewithclinicopathologicalcharacteristicsandsurvival
AT donnaalbertson genomicalterationsinprimarygastricadenocarcinomascorrelatewithclinicopathologicalcharacteristicsandsurvival
AT gerritameijer genomicalterationsinprimarygastricadenocarcinomascorrelatewithclinicopathologicalcharacteristicsandsurvival